Completing tuberculosis prophylaxis in jail: targeting treatment and a comparison of rifampin/pyrazinamide with isoniazid regimens

被引：0
|
作者：
Lambert, LA [1 ]
Ijaz, K [1 ]
Navin, TR [1 ]
机构：
[1] Ctr Dis Control & Prevent, Div TB Eliminat, Dept Hlth & Human Serv, DTBE, Atlanta, GA 30333 USA
来源：
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE | 2005年 / 9卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：230 / 230
页数：1
相关论文
共 50 条
  • [21] PYRAZINAMIDE-ISONIAZID - COMPARISON WITH ISONIAZID-PARA-AMINOSALICYLIC ACID IN ACTIVE PULMONARY TUBERCULOSIS WITH THE CHOICE OF REGIMENS DETERMINED BY CHANCE
    PHILLIPS, S
    HORTON, GE
    AMERICAN REVIEW OF TUBERCULOSIS AND PULMONARY DISEASES, 1956, 73 (05): : 704 - 715
  • [22] ANTAGONISM BETWEEN ISONIAZID AND THE COMBINATION PYRAZINAMIDE-RIFAMPIN AGAINST TUBERCULOSIS INFECTION IN MICE
    GROSSET, J
    TRUFFOTPERNOT, C
    LACROIX, C
    JI, B
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (03) : 548 - 551
  • [23] Therapeutic drug monitoring of isoniazid, rifampin, and pyrazinamide in HIV-infected patients with tuberculosis
    Baniasadi, Shadi
    Fahimi, Fanak
    Tabarsi, Payam
    Nadji, Seyed Alireza
    Khabiri, Shadi
    Shahsavari, Nahid
    Kobarfard, Farzad
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [24] Paradoxical Effect of Isoniazid on the Activity of Rifampin-Pyrazinamide Combination in a Mouse Model of Tuberculosis
    Almeida, Deepak
    Nuermberger, Eric
    Tasneen, Rokeya
    Rosenthal, Ian
    Tyagi, Sandeep
    Williams, Kathy
    Peloquin, Charles
    Grosset, Jacques
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (10) : 4178 - 4184
  • [25] Intestinal Barrier Function and Serum Concentrations of Rifampin, Isoniazid and Pyrazinamide in Patients with Pulmonary Tuberculosis
    Facanha, Monica C.
    Gondim, Argina M. B.
    Pinheiro, Valeria G. F.
    Barroso, Elizabeth C.
    Peloquin, Charles A.
    Guerrant, Richard L.
    Lima, Aldo A. M.
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2009, 13 (03): : 210 - 217
  • [26] HEPATIC TOXICITY OF ANTI-TUBERCULOSIS REGIMENS CONTAINING ISONIAZID, RIFAMPICIN AND PYRAZINAMIDE
    GIRLING, DJ
    TUBERCLE, 1978, 59 (01): : 13 - 32
  • [27] Isoniazid vs. Rifampin for Latent Tuberculosis Infection in Jail Inmates: Toxicity and Adherence
    White, Mary C.
    Tulsky, Jacqueline P.
    Lee, Ju Ruey-Jiuan
    Chen, Lisa
    Goldenson, Joe
    Spetz, Joanne
    Kawamura, L. Masae
    JOURNAL OF CORRECTIONAL HEALTH CARE, 2012, 18 (02) : 131 - 142
  • [28] Initial experience on rifampin and pyrazinamide vs isoniazid in the treatment of latent tuberculosis infection among patients with silicosis in Hong kong
    Leung, CC
    Law, WS
    Chang, KC
    Tam, CM
    Yew, WW
    Chan, CK
    Wong, MY
    CHEST, 2003, 124 (06) : 2112 - 2118
  • [29] Rifampin and pyrazinamide for treatment of latent tuberculosis infection - Reply to Cook
    McElroy, PD
    Ijaz, K
    Navin, TR
    CLINICAL INFECTIOUS DISEASES, 2006, 42 (06) : 892 - 893
  • [30] Safety of 2 months of rifampin and pyrazinamide for treatment of latent tuberculosis
    Stout, JE
    Engemann, JJ
    Cheng, AC
    Fortenberry, ER
    Hamilton, CD
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 167 (06) : 824 - 827
12345